As the deadliest primary brain tumor, glioblastoma is a stubborn foe. In addition to being aggressive, glioblastoma hasn’t responded to immunotherapies that have succeeded against some other types of cancers. Now, University of Florida Health and Massachusetts General Hospital researchers have found a combination approach using those therapies that is showing promise.